Doxycycline Hyclate NDC 42806-362

NDC codes

FDA NDC Directory

Product NDC (as listed)42806-362Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42806-0362Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42806-362-01	42806036201	100 TABLET in 1 BOTTLE (42806-362-01)Marketed from Aug 30, 2019
42806-362-10	42806036210	1000 TABLET in 1 BOTTLE (42806-362-10)Marketed from Aug 30, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline Hyclate
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: EPIC PHARMA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065182
Marketing start: Aug 30, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 42806-362_00848e6e-f161-4fa1-887f-6e598fbf507cSPL ID 00848e6e-f161-4fa1-887f-6e598fbf507cSPL set ID b3cd7b44-db40-4ce5-895e-d4c85a0068aeRxCUI 283535UNII 19XTS3T51U
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442806036201 followed by a unit qualifier and the quantity

Package 42806-0362-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 19, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Doxycycline hyclate tablets, USP are indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis. To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture susceptibility information is available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and s…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065182

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065182
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline Hyclate	Doxycycline hyclate 20 mg/1	TabletOral	Bryant Ranch Prepack	72162-2256
Doxycycline Hyclate	Doxycycline hyclate 20 mg/1	TabletOral	Bryant Ranch Prepack	71335-2526